Inventurus Knowledge Solutions shares list at 43% premium over IPO price

The shares of Inventurus Knowledge Solutions debuted with a 43% premium on Thursday. The shares listed at Rs 1,900 on the NSE over its issue price of Rs 1,329.

Meanwhile, the stock listed at Rs 1,856 on the BSE, indicating 39.65% gain over issue price.

The company's shares were trading with a GMP of Rs 400 in the grey market.


However, it is important to note that grey market premiums are just an indicator as to how the company's shares are stacked up in the unlisted market and are subject to change rapidly.

The IPO of Inventurus received strong response from investors with an overall subscription of 53 times at close. The Rs 2,498 crore IPO is completely an offer for sale (OFS) to 1.87 crore equity shares. Since the IPO is entirely an OFS, the proceeds from the offer will go to the selling shareholders.

Also Read: Catch All Inventurus Knowledge Solutions Share Price Live Updates

Based on annualised FY24 earnings, and fully diluted post-IPO paid-up capital, the company asked for a PE of 54.66x, which seems fully priced looking at the company’s financial growth trajectory.

Founded in 2006, Inventurus Knowledge Solutions offers critical support services to healthcare companies, specializing in areas such as administrative tasks, clinical support, medical documentation management, and virtual medical scribing.

The company’s technology-driven solutions aim to streamline healthcare operations, enhance efficiency, and alleviate administrative burdens, ensuring that healthcare providers can focus more on delivering quality patient care.

Also Read: Sebi board meeting: 10 key changes approved by the regulator that you need to know

As of September 2024, the company has over 778 healthcare organizations as their clients, including health systems, academic medical centres, multi- specialty medical groups, single-specialty medical groups, ancillary healthcare organizations and other outpatient and inpatient healthcare delivery organizations.

Some of the key clients include Mass General Brigham Inc, Texas Health Care PLLC, and The GI Alliance Management.

For the six months ended September 2024, its revenue from operations doubled to Rs 1,283 crore, while profit in the same period rose marginally to Rs 208 crore.